Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Progress in Molecular and Subcellular Biology|November 2, 2006
Spinal muscular atrophy and therapeutic prospectsBrunhilde Wirth, Lars Brichta, Eric HahnenSeminars in Pediatric Neurology|October 10, 2006
Spinal muscular atrophy: from gene to therapyBrunhilde Wirth, Lars Brichta, Eric HahnenPPAR Research|August 30, 2008
Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS TumorsLars Tatenhorst, Eric Hahnen, Michael T HenekaHuman Genetics|May 26, 2006
The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cellsMarkus Riessland, Lars Brichta, Eric Hahnen, et al.Expert Opinion on Drug Discovery|March 15, 2013
Drug discovery for spinal muscular atrophyBrunhilde Wirth Phd, Markus Riessland Msc, Eric Hahnen MbaBreast Care (Basel, Switzerland)|June 15, 2017
Germline Mutations in Triple-Negative Breast CancerEric Hahnen, Jan Hauke, Christoph Engel, et al.Expert Opinion on Investigational Drugs|January 31, 2008
Histone deacetylase inhibitors: possible implications for neurodegenerative disordersEric Hahnen, Jan Hauke, Christian Tränkle, et al.Experimental Brain Research|January 12, 2007
Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cellsFlorian A Siebzehnrubl, Rolf Buslei, Ilker Y Eyupoglu, et al.BMC Medical Genomics|March 28, 2018
Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnosticsCorinna Ernst, Eric Hahnen, Christoph Engel, et al.Journal of Neurosurgery|May 6, 2005
Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical noteIlker Y Eyüpoglu, Eric Hahnen, Alexandra Heckel, et al.Pageof 15